Core Insights - Synopsys (SNPS) is currently in Phase 10 of its 18-phase Adhishthana Cycle, with indications that a peak may have already been reached, suggesting potential bearish trends in upcoming phases [1][8] Synopsys's Cycle So Far - From Phase 9, Synopsys experienced a significant rally, gaining approximately 223%, attributed to the "Supreme Move" phase as defined by Adhishthana Principles [4] - The stock has shown signs of a peak at the 18th bar of Phase 10, having corrected by around 20% from its high of $629.38 [5] Phase Durations - Phase 10 is set to conclude on August 2, 2026, with indications that SNPS may not reclaim its previous high within this timeframe [8] - The subsequent Phase 11 will commence on August 3, 2026, and extend until March 2, 2031 [7] Weekly Chart Outlook - On the weekly chart, Synopsys has entered Phase 9, typically associated with strong breakouts; however, the cakra built between Phases 4-8 was unsuccessful, leading to trading below the lower band, indicating potential underperformance [9]

Core Insights - Zscaler (ZS) is currently in the 10th Phase of its 18 Phase Adhishthana Cycle, having rallied approximately 33% since entering this phase [1] - The stock has shown a 66.66% alignment with the Adhishthana Principles, a framework for forecasting stock behavior through cyclical analysis [1] Phase Analysis - In Phase 2, Zscaler experienced a consolidation range with a bearish tilt for 37 bars, followed by a sharp bullish rally of roughly 225%, termed the Rally of Buddhi [2][4] - Phase 4 began at $191.14, with the stock reaching a high of $376.11, but this rally was deemed illusory, leading to a renunciation phase in Phase 5 where Zscaler dropped below the Phase 4 low of $125.12 [5] - Phase 6 established a Level of Nirvana at $146.93, which now serves as a key valuation barometer during bearish phases [7] Current and Future Outlook - Zscaler is in Phase 10, which often marks the beginning of an ascent towards the Adhishthana Himalayan Formation, with expectations of a peak formation occurring between the 18th and 23rd bars of Phase 10, translating to a window between 2 September and 12 October 2025 [10] - On the monthly timeframe, Zscaler is in Phase 2, having begun a classic Rally of Buddhi after consolidating for 38 bars, with this phase scheduled to end on 31 January 2028 [13] Investor Considerations - Zscaler did not deliver a significant move in Phase 9 on the weekly charts, which is typically expected, and its weekly alignment percentage is lower compared to some peers [16] - The company remains a strong hold, with investors advised to monitor the period from 2 September to 12 October 2025 for potential peak formation in Phase 10 [17]

Core Viewpoint - CrowdStrike is currently in its 8th Phase of the Adhishthana Cycle, and while the stock appears bullish, there are indications that recent gains may not be sustainable, warranting caution among investors [1][9]. Group 1: Current Position and Alignment - CrowdStrike has maintained an 85.71% alignment with the Adhishthana Principles, which forecast stock behavior through cyclical analysis [2]. - The stock is completing a Cakra, a curved bullish channel spanning Phases 4 through 8, which is expected to guide price movement until the end of Phase 8 [8][11]. Group 2: Key Structural Elements - In Phase 6, CrowdStrike established a Level of Nirvana at $286.11, which serves as a critical valuation anchor for future phases [5]. - The Cakra channel is currently respected, and a breakout above this channel during Phase 8 is deemed highly unlikely, with true breakouts expected in Phase 9 [11][12]. Group 3: Future Outlook - A retest of the lower boundary near the Nirvana level of $286.11 is likely before any decisive breakout occurs [13]. - Investors holding long positions should consider hedging their exposure, while new entrants may benefit from waiting for the stock to approach the Nirvana level for a more favorable entry point [13].

Core Insights - Regeneron Pharmaceuticals (REGN) has been in a downtrend for over 280 days, currently in the 10th Phase of its 18-Phase Adhishthana Cycle, indicating a significant structural breakdown rather than mere technical fluctuations [1][15]. Historical Performance - The current Adhishthana Cycle for Regeneron began on January 29, 2018, with the stock initially following expected market behaviors until Phase 9 [2]. - In Phase 2, Regeneron experienced a strong Rally of Buddhi, surging approximately 113% after a consolidation period of 37 bars [5]. - Phase 3 saw a slight rally followed by a rounded top, leading to a decline of about 33%, aligning with the Adhishthana framework [8]. - Phase 6 established a Nirvana Level at $671.41, which now serves as a valuation benchmark [10]. Phase 9 Breakdown - Phase 9 typically marks a breakout above the bullish "Cakra" channel, but Regeneron broke downwards, leading to a significant decline [13]. - This breakdown triggered the Move of Pralaya, resulting in a collapse of bullish sentiment and a stock price drop of approximately 54% since the break [14]. Future Outlook - Currently in Phase 10, Regeneron is in a state of structural limbo, with no meaningful recovery expected until it enters the Guna Triads (Phases 14, 15, and 16), which begin on February 7, 2028 [15]. - The current structure suggests continued weakness and uncertainty for the stock until the completion of the Guna Triads [15].

Core Insights - Thermo Fisher Scientific Inc. (TMO) is currently in the 18th and final phase of the Adhishthana Cycle across both weekly and monthly timeframes, indicating a transitional moment for the stock [3][12] - The stock has experienced a decline of 38% since entering the 18th phase, primarily due to bearish sentiment reflected in the weekly chart [6][10] - The monthly chart presents a contrasting narrative, suggesting potential for long-term upside, but the current weakness is driven by the bearish signals on the weekly chart [10][11] Weekly Chart Analysis - The Guna Triads for TMO in phases 14-16 were dominated by Rajoguna and Tamoguna, indicating indecision, volatility, and bearish sentiment [6][5] - The bearish 18th phase on the weekly chart is expected to continue until November 30, 2025, keeping the stock under pressure [10][11] - The 'Death Move' pattern suggests a significant correction after entering Phase 18 before potentially reaching Nirvana [10] Monthly Chart Analysis - The Guna Triads for the monthly chart in phases 14-16 were characterized by Satoguna, indicating a more constructive outlook [10] - The bullish signals on the monthly chart are anticipated to take precedence only after the conclusion of the bearish weekly phase in late 2025 [11] - The monthly Phase 18 does not conclude until July 31, 2030, suggesting long-term upside potential remains viable [12] Investment Strategy - Clients pursuing shorter timeframes have been implementing bearish spreads since the initiation of the weekly 18th phase [11] - A shift towards increased bullish exposure is expected post-2025 as the long-term value and Nirvana setup on the monthly chart becomes dominant [11] - TMO is positioned as a compelling candidate for patient investors looking to capitalize on deep-cycle insights, provided they time their investments appropriately [12]

Core Viewpoint - Blackstone Inc. is currently in the 6th Phase of its 18-Phase Adhishthana Cycle, with potential for value accumulation, but significant breakout may not occur until late 2026 [1][16]. Group 1: Current Cycle Analysis - Blackstone has completed one full 18-phase Adhishthana Cycle and is currently in its 6th cycle, which began on October 11, 2021, showing a 99% alignment with Adhishthana Principles [2][3]. - The stock is expected to revisit the low of the previous phase before moving higher, having already completed this retest, making current valuations attractive [6][12]. Group 2: Valuation Insights - The Level of Nirvana for Phase 6 will be confirmed on October 19, 2025, and if Blackstone remains below this level, it will be considered a long-term value play [7][13]. - The anticipated Level of Nirvana is estimated to settle around $129–$130, based on recent highs and potential price movements [13]. Group 3: Future Projections - Late 2026 is critical for Blackstone as it is expected to enter Phase 9 of its weekly Adhishthana Cycle, which is characterized by significant breakout potential [14][15]. - Current price levels suggest a solid long-term value case, with short-term corrections towards $104 being probable and healthy before a potential breakout [15][16].

Group 1 - Novo Nordisk has entered the 18th and final phase of its long-term Weekly Adhishthana Cycle, indicating a potentially transformative period for the stock [1][2] - The stock has shown an 88.5% alignment with the Adhishthana Principles on the weekly timeframe since the cycle began on December 23, 2013, with Phase 18 expected to run until November 8, 2026 [2] - The trajectory of Phase 18 is influenced by the previous phases, particularly Phases 14, 15, and 16, which exhibited bullish characteristics [5][8] Group 2 - The Guna Triads indicate that the chances of the stock reaching its Nirvana are high due to the SSR formation, which consists of two Satoguna phases followed by a Rajoguna phase [7][8] - However, the monthly charts present a contrasting view, showing that Novo is currently in Phase 11, which typically leads to a peak followed by a correction [11][13] - The monthly alignment is only around 60-65%, significantly lower than the weekly alignment, which raises concerns about the reliability of the monthly signals [14] Group 3 - The Nirvana target on the weekly chart is nearly 129% above current levels, suggesting significant potential for growth [15] - The conflicting signals between the weekly and monthly cycles create a high-risk, high-reward scenario for investors [15][16] - The stock is technically bullish on the weekly chart but structurally unresolved on the monthly chart, indicating a pivotal juncture for Novo Nordisk [16]